Related Experiment Video

Updated: Jun 17, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

[Advance in biomarkers of lung cancer in diagnosis and targeted therapy]

Jing Zhang, Zhi-yong Liang, Xuan Zeng

    Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology
    |December 22, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
    08:14

    MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

    Published on: October 26, 2017

    Related Experiment Videos

    Last Updated: Jun 17, 2026

    Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
    07:59

    Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

    Published on: September 8, 2023

    MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
    08:14

    MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

    Published on: October 26, 2017

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...

    Articles linked to this work by shared authors, journal, and citation graph.

    Identification of proteins involved in microglial endocytosis of alpha-synuclein.

    Journal of proteome research·2007

    Different supramolecular assemblies in two 1:1 proton-transfer compounds of sulfobenzoic acids with aromatic amines.

    Acta crystallographica. Section C, Crystal structure communications·2007

    Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy.

    The American journal of pathology·2007

    Biomarkers for Alzheimer's disease.

    Expert review of neurotherapeutics·2007

    [Role of sympathetic nerve activity and arterial endothelial function in pathogenesis of hypertension in patients with obstructive sleep apnea-hypopnea syndrome].

    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases·2007

    Subsequently enhanced CPP to morphine following chronic but not acute footshock stress associated with corticosterone mechanism in rats.

    The International journal of neuroscience·2007

    [Clinicopathological and molecular genetic characteristics of embryonal rhabdomyosarcoma with divergent neuroectodermal differentiation: an analysis of 17 cases].

    Zhonghua bing li xue za zhi = Chinese journal of pathology·2026

    [Comparative analysis of clinicopathological features of allergic fungal rhinosinusitis and eosinophilic mucin rhinosinusitis].

    Zhonghua bing li xue za zhi = Chinese journal of pathology·2026

    [Relationship between tumor regression pattern and prognosis after neoadjuvant therapy for breast cancer].

    Zhonghua bing li xue za zhi = Chinese journal of pathology·2026

    [Clinicopathological and molecular characteristics of primary small cell neuroendocrine carcinoma of the breast: an analysis of nine cases].

    Zhonghua bing li xue za zhi = Chinese journal of pathology·2026

    [Malignant phyllodes tumor of the breast with distant metastasis: a clinicopathological and molecular genetic analysis of ten cases].

    Zhonghua bing li xue za zhi = Chinese journal of pathology·2026

    [Controversies and advances in pathological diagnosis of breast neuroendocrine neoplasms].

    Zhonghua bing li xue za zhi = Chinese journal of pathology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us